Parkinson's disease incidence and prevalence assessment in France using the national healthcare insurance database

European Journal of Neurology

Volumn 22, Issue 3, 2015, Pages 464-471

  Blin, P ^a,b   Dureau Pournin, C ^a,b   Foubert Samier, A ^c,d   Grolleau, A ^b,e   Corbillon, E ^f   Jove J ^a,b   Lassalle, R ^a,b   Robinson, P ^a,b   Poutignat, N ^f   Droz Perroteau, C ^a,b   Moore, N ^b,d,e,g  

^a ADERA   (France)

^b Centre of Clinical Investigation Clinical Epidemiology   (France)

^c INSERM   (France)

^d BORDEAUX UNIVERSITY HOSPITAL   (France)

^e UNIVERSITÉ DE BORDEAUX   (France)

^f Haute Autorité de santé   (France)

^g INSERM U657   (France)

Author keywords

Database management systems; Health insurance reimbursement; Hospital information system; Incidence; Parkinson disease; Prevalence

Indexed keywords

ADULT; AGED; ARTICLE; CHRONIC DISEASE; CROSS-SECTIONAL STUDY; FEMALE; FRANCE; GROUPS BY AGE; HEALTH CARE PLANNING; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; NATIONAL HEALTH INSURANCE; PARKINSON DISEASE; PREVALENCE; PRIORITY JOURNAL; PUBLIC HEALTH; REIMBURSEMENT; SEX DIFFERENCE; FACTUAL DATABASE; HEALTH INSURANCE; MIDDLE AGED; STATISTICS AND NUMERICAL DATA; UNITED STATES; VERY ELDERLY;

AGED; AGED, 80 AND OVER; CROSS-SECTIONAL STUDIES; DATABASES, FACTUAL; FEMALE; FRANCE; HUMANS; INCIDENCE; INSURANCE, HEALTH; MALE; MIDDLE AGED; PARKINSON DISEASE; PREVALENCE; UNITED STATES;

EID: 84922607390     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/ene.12592     Document Type: Article

References (21)

1. Samii A, Nutt JG, Ransom BR. Parkinson's disease. Lancet 2004; 363: 1783-1793.
2. Davie CA. A review of Parkinson's disease. Br Med Bull 2008; 86: 109-127.
3. de Rijk MC, Launer LJ, Berger K, et al. Prevalence of Parkinson's disease in Europe: a collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. Neurology 2000; 54: S21-S23.
4. Moisan F, Elbaz A. Maladie de Parkinson parmi les affiliés à la Mutualité sociale agricole dans cinq départements. Modèles prédictifs à partir des bases de remboursement de médicaments. Saint-Maurice: Institut de veille sanitaire; 2012. http://www.invs.sante.fr (accessed 22/04/2014).
5. Tison F, Dartigues JF, Dubes L, Zuber M, Alperovitch A, Henry P. Prevalence of Parkinson's disease in the elderly: a population study in Gironde, France. Acta Neurol Scand 1994; 90: 111-115.
6. Munoz M, Boutros-Toni F, Preux PM, et al. Prevalence of neurological disorders in Haute-Vienne department (Limousin region - France). Neuroepidemiology 1995; 14: 193-198.
7. Munoz M, Dumas M, Boutros-Toni F, et al. A neuro-epidemiologic survey in a Limousin town. Rev Neurol 1988; 144: 266-271.
8. von Campenhausen S, Bornschein B, Wick R, et al. Prevalence and incidence of Parkinson's disease in Europe. Eur Neuropsychopharmacol 2005; 15: 473-490.
9. Fender P, Paita M, Ganay D, Benech JM. Prevalence of thirty long term disorders for French health insurance members in 1994. Rev Epidemiol Sante Publique 1997; 45: 454-464.
10. Lajugie D, Bertin N, Chantelou ML, et al. The prevalence of Parkinson's disease and its cost to the French national health fund in metropolitan France in 2000. Rev Med Ass Maladie 2005; 36: 113-122.
11. Martin-Latry K, Begaud B. Pharmacoepidemiological research using French reimbursement databases: yes we can!. Pharmacoepidemiol Drug Saf 2010; 19: 256-265.
12. Tuppin P, de Roquefeuil L, Weill A, Ricordeau P, Merliere Y. French national health insurance information system and the permanent beneficiaries sample. Rev Epidemiol Sante Publique 2010; 58: 286-290.
13. Haute Autorité de Santé. Guide du parcours de soins. Maladie de Parkinson;. 2012. http://www.has-sante.fr (accessed 22/04/2014).
14. Institut national de la statistique et des études économiques. Pyramides des âges (Population totale par sexe et âge - France et France métropolitaine). http://www.insee.fr/fr/themes/detail.asp?reg_id=0&ref_id=bilan-demo (accessed 22/04/2014).
15. Caslake R, Taylor K, Scott N, et al. Age-, gender-, and socioeconomic status-specific incidence of Parkinson's disease and parkinsonism in northeast Scotland: the PINE study. Parkinsonism Relat Disord 2013; 19: 515-521.
16. Taylor KS, Cook JA, Counsell CE. Heterogeneity in male to female risk for Parkinson's disease. J Neurol Neurosurg Psychiatry 2007; 78: 905-906.
17. Van Den Eeden SK, Tanner CM, Bernstein AL, et al. Incidence of Parkinson's disease: variation by age, gender, and race/ethnicity. Am J Epidemiol 2003; 157: 1015-1022.
18. Chevreul K, Durand-Zaleski I, Bahrami SB, Hernandez-Quevedo C, Mladovsky P. France: health system review. Health Sys Transit 2010; 12: 1-291 xxi-xxii.
19. Feldman AL, Johansson AL, Gatz M, et al. Accuracy and sensitivity of parkinsonian disorder diagnoses in two Swedish national health registers. Neuroepidemiology 2012; 38: 186-193.
20. Swarztrauber K, Anau J, Peters D. Identifying and distinguishing cases of parkinsonism and Parkinson's disease using ICD-9 CM codes and pharmacy data. Mov Disord 2005; 20: 964-970.
21. Szumski NR, Cheng EM. Optimizing algorithms to identify Parkinson's disease cases within an administrative database. Mov Disord 2009; 24: 51-56.